PRINCETON, N.J., May 27 /PRNewswire-FirstCall/ -- Orchid Cellmark Inc. (Nasdaq: ORCH), a leading worldwide provider of identity DNA testing services, today announced a change in its sales and marketing organization.
Jeffrey S. Boschwitz, Ph.D. has been appointed Vice President of North America Marketing and Sales. Based in Orchid Cellmark's corporate headquarters in Princeton New Jersey, Mr. Boschwitz will oversee sales and marketing for Orchid's North America business.
Mr. Boschwitz brings extensive strategic marketing experience to Orchid Cellmark. Most recently, he served as Director of Marketing, Planning, Analysis and Research at Quest Diagnostics, for the company's physician diagnostics business division. As part of that role, Mr. Boschwitz was responsible for development of the marketing plan and optimizing sales force effectiveness. Previously, Mr. Boschwitz was a Principal in Booz Allen Hamilton's health care practice with a focus on the diagnostics and pharmaceutical industries. Earlier in his career, he was a Project Manager for Plan A Consulting, where he led projects to optimize the value of new product pipelines for both large and entrepreneurial life sciences companies. Mr. Boschwitz received a B.S. in biology and a Ph.D. in immunology from Cornell University and completed his postdoctoral work at Stanford University.
Thomas A. Bologna, Chief Executive Officer of Orchid Cellmark said, "We
believe that Jeff's combination of analytical skills and strategic insight
will be of significant value in leading our North America marketing and
sales activities. Jeff has achieved success across industries and sectors
in developing and implementing a wide variety of innovative business
solutions. We believe that his
|SOURCE Orchid Cellmark Inc.|
Copyright©2008 PR Newswire.
All rights reserved